Brevan Howard Capital Management »

Rigel Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $15k 10k 1.45

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf (HYG)
Consumer Staples Spdr Sbi Cons Stpls (XLP)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
Health Care Select Secto Sbi Healthcare Call Option (XLV)
Ishares Jp Morgan Usd Emerging Markets Jpmorgan Ud Emg (EMB)
ISHARES 20plus YR TREAS 20 Yr Tr Bd Etf Call Option (TLT)
KraneShares CSI China Internet ETF Csi Chi Internet (KWEB)
Ishares Ftse/xinhua China 25 China Lg-cap Etf (FXI)
Ishares Msci Eafe Index Fund Msci Eafe Etf Put Option (EFA)
Ishares Msci Brazil Msci Brazil Etf (EWZ)
Kbw Regional Banking Etf S&p Regl Bkg Call Option (KRE)
Vnet 0 02/26 Note 2/0 (Principal)

View all positions for Brevan Howard Capital Management

Top funds holding Rigel Pharmaceuticals

Soleus Capital Management
Vanguard Group
Jacobs Levy Equity Management
Assenagon Asset Management
CM Management
GSA Capital Partners
Sphera Funds Management
Millennium Management
Charles Schwab Investment Management
Two Sigma Advisers
Thomas Stevens, CFA"
Connor, Clark & Lunn Investment Management
Bank of New York Mellon
Goldman Sachs Group
Squarepoint Ops

View all funds holding Rigel Pharmaceuticals